MoneyWorks4Me

Hester Biosciences - Quaterly Results

17 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 606.96 millions, about 20.79% up against Rs. 502.51 millions recorded during the year-ago period.An average growth of 26.58% was recorded for the quarter ended March 2023 to Rs. 62.63  millions from Rs. 49.48 millions.Operating profit surged to 118.69 millions from the corresponding previous quarter of 111.35 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 606.96 502.51 20.79 2540.00 2193.51 15.80 2540.00 2193.51 15.80
Other Income 9.50 10.81 -12.12 53.23 46.57 14.30 53.23 46.57 14.30
PBIDT 118.69 111.35 6.59 602.09 652.26 -7.69 602.09 652.26 -7.69
Interest 3.48 13.83 -74.84 64.97 24.68 163.25 64.97 24.68 163.25
PBDT 115.21 97.52 18.14 537.12 627.58 -14.41 537.12 627.58 -14.41
Depreciation 26.21 25.48 2.86 97.88 95.02 3.01 97.88 95.02 3.01
PBT 89.00 72.04 23.54 439.24 532.56 -17.52 439.24 532.56 -17.52
TAX 26.37 22.56 16.89 115.82 137.39 -15.70 115.82 137.39 -15.70
Deferred Tax 3.47 2.92 18.84 8.55 -5.14 -266.34 8.55 -5.14 -266.34
PAT 62.63 49.48 26.58 323.42 395.17 -18.16 323.42 395.17 -18.16
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 19.55 22.16 -11.75 23.70 29.74 -20.28 23.70 29.74 -20.28
Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..